Related Experiment Video

Updated: May 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

11.9K

Advances in antifungal therapy

Carole A Sable1, Kim M Strohmaier, Jeffrey A Chodakewitz

  • 1Novexel SA, Romainville, France. carole.sable@novexel.com

Annual Review of Medicine
|October 31, 2007
PubMed

Insights

Invasive fungal infections (IFIs) are rising in immunocompromised patients. Advances in antifungal drugs and diagnostics offer new hope, but research continues for optimal treatment strategies.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Clinical Medicine

Background:

  • Increasing prevalence of invasive fungal infections (IFIs) over 30 years.
  • IFIs are linked to significant patient morbidity and mortality.
  • Rise in immunocompromised hosts contributes to IFI incidence.

Purpose of the Study:

  • To review recent advances in antifungal therapy and diagnostics for IFIs.
  • To highlight ongoing research into novel treatment strategies for IFIs.
  • To address the need for optimal management of serious fungal infections.

Main Methods:

  • Review of recent advancements in antifungal pharmacotherapy.
  • Analysis of new diagnostic tools for IFIs.
  • Discussion of emerging treatment strategies like combination and pre-emptive therapy.

Main Results:

  • Introduction of broad-spectrum triazoles (voriconazole, posaconazole) and echinocandins (caspofungin, micafungin, anidulafungin).
  • Integration of galactomannan and beta-glucan tests into diagnostic criteria (EORTC/MSG).
  • Investigation of combination and pre-emptive therapy approaches.

Conclusions:

  • Significant progress in antifungal treatments and diagnostics for IFIs.
  • Unanswered questions persist regarding optimal management of serious fungal infections.
  • Continued research is crucial for developing new therapies and management strategies.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

20.2K
Quantifying the Antifungal Activity of Peptides Against Candida albicans06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.8K

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
787
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
115